Biotech

All Articles

8 months after a $213M fundraise, genetics publisher Tome helps make cuts

.After rearing $213 million in 2023-- some of the year's largest personal biotech shots-- Volume Bio...

BioMarin develops director group along with biotech veterinarians-- Chutes &amp Ladders

.Accept to today's Chutes &amp Ladders, our summary of notable leadership hirings, firings and retir...

Biopharma Q2 VC struck highest level since '22, while M&ampA slowed

.Financial backing funding in to biopharma rose to $9.2 billion across 215 deals in the 2nd one-four...

Bicara, Zenas find IPOs to drive late-phase assets towards market

.Bicara Rehabs as well as Zenas Biopharma have delivered new impetus to the IPO market with filings ...

Genentech to finalize cancer immunology research study team

.Genentech will definitely shut its cancer immunology research department, as well as device mind as...

Kezar drops sound lump but to show its truly worth in period 1 test

.Kezar Lifestyle Sciences is actually dropping its unpromising period 1 sound growth drug as the bio...

Acelyrin falls izokibep, dismisses 3rd of personnel

.In spite of izokibep preserving its own newfound winning streak in the facility, Acelyrin is actual...

Rivus' stage 2 obesity-related cardiac arrest test strikes endpoint

.Rivus Pharmaceuticals has plumped up the potential customers of its fat-busting, muscle-sparing dru...

Ovid stops preclinical job, IV program after soticlestat neglect

.Ovid Therapy presently showed last month that it was trimming its own headcount as the company gets...

Eli Lilly opens up $700M nucleic acid R&ampD facility in Boston Port

.Eli Lilly has actually opened up a $700 thousand R&ampD facility in the Boston ma Port, increasing ...